The girl, who was admitted to Aster CMI Hospital with alarming breathlessness and significant pallor, was diagnosed with ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that targets ...

GSK announced on Friday that its monoclonal antibody ‘Nucala’, or mepolizumab, has received approval from China's National ...

Equities researchers at HC Wainwright started coverage on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report) in ...

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Microscopic Polyangiitis (MPA).

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Allergic Rhino-Conjunctivitis.

Barclays PLC purchased a new position in shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...